Summary & Overview
CPT 0951T: Implantation of Active Middle Ear Hearing Implant
CPT code 0951T represents the surgical placement of a totally implantable active middle ear implant (AMEI), including mastoidectomy, device implantation, and attachment of the sound processor. This procedure addresses moderate-to-severe conductive or mixed hearing loss and is an alternative to conventional hearing aids or other implantable hearing devices. Nationally, the code captures a specialized otologic surgical service with implications for surgical resource use, device coverage policies, and durable medical device reimbursement.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications and the typical settings in which the service is performed, plus an outline of the policy and coding considerations that influence coverage and billing workflows. The publication summarizes available benchmarks and payment policy trends relevant to implantable hearing devices, highlights common billing modifiers and operational considerations, and clarifies clinical context for surgical teams and billing staff.
The analysis is intended for clinicians, hospital billing departments, and policy analysts seeking a national perspective on coding, payment, and clinical use of AMEI implantation services. Data not available in the input will be noted where relevant.
Billing Code Overview
CPT code 0951T describes the surgical placement of a totally implantable active middle ear implant (AMEI) for a patient with hearing loss. The procedure includes performing a mastoidectomy to prepare the surgical site, surgically implanting the device, and attaching the sound processor.
Service type: Surgical implant procedure (otologic surgery)
Typical site of service: Hospital operating room or ambulatory surgical center, where otologic surgical procedures and mastoidectomies are performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with moderate-to-severe sensorineural or mixed hearing loss who has tried and had limited benefit from conventional hearing aids, or has anatomical or chronic ear disease making hearing aids ineffective. The patient presents to an otolaryngologist (otologist or neurotologist) for audiologic evaluation, imaging, and surgical candidacy assessment. Preoperative workup includes comprehensive audiometry, speech discrimination testing, and high-resolution CT of the temporal bones to assess mastoid and middle ear anatomy. The multidisciplinary workflow involves the otolaryngologist, audiologist, and device representative. In the operating room under general anesthesia, the surgeon performs a mastoidectomy to create surgical access, implants the totally implantable active middle ear implant (AMEI) components in the mastoid/middle ear, secures the transducer to the ossicular chain or appropriate middle ear structure, places the implantable generator in a subperiosteal or subcutaneous pocket, and attaches the internal receiver. The procedure concludes with closure and activation planning; postoperative care includes wound checks, audiology programming, and device activation at a follow-up visit typically several weeks after surgery.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When the work, time, or complexity substantially exceeds the typical for 0951T due to extensive mastoid or reconstructive work. |